A detailed history of Canada Pension Plan Investment Board transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 284,004 shares of VRTX stock, worth $116 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
284,004
Previous 337,116 15.75%
Holding current value
$116 Million
Previous $158 Million 16.41%
% of portfolio
0.13%
Previous 0.16%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$460.0 - $505.78 $24.4 Million - $26.9 Million
-53,112 Reduced 15.75%
284,004 $132 Million
Q2 2024

Aug 12, 2024

SELL
$392.81 - $485.53 $19.5 Million - $24 Million
-49,532 Reduced 12.81%
337,116 $158 Million
Q1 2024

May 14, 2024

BUY
$407.69 - $446.08 $11.7 Million - $12.8 Million
28,747 Added 8.03%
386,648 $162 Million
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $3.11 Million - $3.73 Million
9,077 Added 2.6%
357,901 $146 Million
Q3 2023

Nov 09, 2023

BUY
$338.18 - $362.46 $20.3 Million - $21.7 Million
59,923 Added 20.74%
348,824 $121 Million
Q2 2023

Aug 09, 2023

SELL
$314.42 - $351.91 $7.55 Million - $8.45 Million
-24,025 Reduced 7.68%
288,901 $102 Million
Q1 2023

May 12, 2023

BUY
$283.23 - $323.1 $9.5 Million - $10.8 Million
33,525 Added 12.0%
312,926 $98.6 Million
Q4 2022

Feb 14, 2023

SELL
$285.76 - $321.48 $379 Million - $426 Million
-1,326,453 Reduced 82.6%
279,401 $80.7 Million
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $11.8 Million - $13.2 Million
-43,120 Reduced 2.61%
1,605,854 $465 Million
Q2 2022

Aug 12, 2022

BUY
$234.96 - $292.55 $2.1 Million - $2.62 Million
8,943 Added 0.55%
1,648,974 $465 Million
Q1 2022

May 13, 2022

SELL
$221.42 - $260.97 $15.1 Million - $17.8 Million
-68,323 Reduced 4.0%
1,640,031 $428 Million
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $2.75 Million - $3.48 Million
15,560 Added 0.92%
1,708,354 $375 Million
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $16.3 Million - $18.3 Million
-89,957 Reduced 5.05%
1,692,794 $307 Million
Q2 2021

Aug 16, 2021

BUY
$187.49 - $221.1 $104 Million - $123 Million
555,276 Added 45.24%
1,782,751 $359 Million
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $243 Million - $283 Million
1,174,177 Added 2203.04%
1,227,475 $264 Million
Q4 2020

Feb 17, 2021

SELL
$207.01 - $276.09 $3.3 Million - $4.41 Million
-15,965 Reduced 23.05%
53,298 $12.6 Million
Q3 2020

Nov 12, 2020

SELL
$255.65 - $303.1 $1.02 Million - $1.21 Million
-4,000 Reduced 5.46%
69,263 $18.8 Million
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $5.67 Million - $7.43 Million
25,127 Added 52.2%
73,263 $21.3 Million
Q1 2020

May 13, 2020

SELL
$199.77 - $247.81 $11.6 Million - $14.4 Million
-58,069 Reduced 54.68%
48,136 $11.5 Million
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $43.3 Million - $58.1 Million
-259,615 Reduced 70.97%
106,205 $23.3 Million
Q3 2019

Nov 12, 2019

SELL
$166.23 - $187.09 $674,893 - $759,585
-4,060 Reduced 1.1%
365,820 $62 Million
Q2 2019

Aug 12, 2019

SELL
$164.61 - $190.37 $14.1 Million - $16.3 Million
-85,701 Reduced 18.81%
369,880 $67.8 Million
Q1 2019

May 15, 2019

BUY
$163.73 - $194.7 $3.8 Million - $4.52 Million
23,208 Added 5.37%
455,581 $83.8 Million
Q4 2018

Feb 06, 2019

BUY
$151.91 - $192.21 $13.4 Million - $16.9 Million
88,000 Added 25.55%
432,373 $71.6 Million
Q3 2018

Nov 09, 2018

BUY
$167.73 - $192.74 $407,583 - $468,358
2,430 Added 0.71%
344,373 $66.4 Million
Q2 2018

Aug 07, 2018

BUY
$145.72 - $169.96 $3.34 Million - $3.89 Million
22,888 Added 7.17%
341,943 $58.1 Million
Q1 2018

May 14, 2018

SELL
$151.6 - $177.13 $4.02 Million - $4.69 Million
-26,500 Reduced 7.67%
319,055 $52 Million
Q4 2017

Feb 14, 2018

BUY
$137.28 - $155.55 $21.4 Million - $24.3 Million
155,900 Added 82.2%
345,555 $51.8 Million
Q3 2017

Oct 30, 2017

BUY
$148.13 - $162.24 $12.2 Million - $13.3 Million
82,200 Added 76.5%
189,655 $28.8 Million
Q2 2017

Jan 31, 2018

SELL
N/A
-140,068 Reduced 56.59%
107,455 $13.8 Million
Q1 2017

Jan 31, 2018

BUY
N/A
247,523
247,523 $27.1 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.